The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...
1don MSN
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
7hon MSN
Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...
The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...
In a big breakthrough, Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India following approval from the ...
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
ABP News on MSN14h
Mounjaro Enters India: The Weight Loss & Diabetes Drug May Have These Side Effects; Know PriceEli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback